{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:17:20Z","timestamp":1787847440620,"version":"build-2784847793"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      This study evaluates\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      anti-\n                      <jats:italic toggle=\"yes\">Toxoplasma<\/jats:italic>\n                      effects of copper nanoparticles (CuNPs) green synthesized using\n                      <jats:italic toggle=\"yes\">Conocarpus erectus<\/jats:italic>\n                      L.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      CuNPs were green synthesized using the aqueous extract of\n                      <jats:italic toggle=\"yes\">Conocarpus erectus<\/jats:italic>\n                      L. An MTT assay was performed on Hella cells to evaluate the cell viability. The\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      anti-\n                      <jats:italic toggle=\"yes\">Toxoplasma<\/jats:italic>\n                      activity of various concentrations of CuNPs (20\u2013160 ppm) for 1, 2, 4, and 8 h at room temperature was assessed against the\n                      <jats:italic toggle=\"yes\">Toxoplasma gondii<\/jats:italic>\n                      RH tachyzoites. Moreover, the flow cytometry test was carried out to confirm the results. For\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      assessment, BALB\/c mice were infected with RH strains, subsequently treated with CuNPs, and compared with the control group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      CuNPs had a particle size of less than 20 nm, with a maximum peak at 315 nm, according to transmission electron microscopy. The highest mortality rate was observed at 160 ppm concentration, and after 8 h of exposure, it was demonstrated by the result of flow cytometry. Furthermore, oral administration of CuNPs increased oral bioavailability and mice survival time and reduced parasitemia. Green synthesized CuNPs by\n                      <jats:italic toggle=\"yes\">Conocarpus erectus<\/jats:italic>\n                      L. reduced the tachyzoites of\n                      <jats:italic toggle=\"yes\">Toxoplasma gondii<\/jats:italic>\n                      , RH strain\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      , and increased the survival time of infected mice treated with CuNPs compared to the control group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>To achieve effective treatment against toxoplasmosis, it is suggested that more studies will be done on other strains, especially type II. Finally, it seems that the use of CuNPs can be helpful as a supplementary treatment alongside common treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_401_23","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:00:09Z","timestamp":1780138809000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anti-Toxoplasma Activity of Copper Nanoparticles (CuNPs) Synthesized Using Conocarpus erectus L.: An In Vitro and In Vivo Study"],"prefix":"10.4103","volume":"15","author":[{"given":"Bahram","family":"Rostami","sequence":"first","affiliation":[{"name":"Department of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Hasanpour","sequence":"additional","affiliation":[{"name":"Department of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran"},{"name":"Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Jafarpour Azami","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Roozbehani","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeideh","family":"Hashemi-Hafshejani","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Raiesi","sequence":"additional","affiliation":[{"name":"Department of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran"},{"name":"Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad I.","family":"Getso","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, Faculty of Clinical Sciences, College of Health Sciences, Bayero University Kano, PMB 3011, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Badirzadeh","sequence":"additional","affiliation":[{"name":"Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Falahi","sequence":"additional","affiliation":[{"name":"Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Pakzad","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran"},{"name":"Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Davoodzadeh","family":"Gholami","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesam","family":"Yousefi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Care, Sajad Hospital, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razi","family":"Naserifar","sequence":"additional","affiliation":[{"name":"Department of Parasitology and Mycology, School of Allied Medical Sciences, Ilam University of Medical Sciences, Ilam, Iran"},{"name":"Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3]]},"reference":[{"key":"R1-20260530","doi-asserted-by":"crossref","first-page":"68","DOI":"10.31083\/ph.2021.0100","article-title":"Spiramyin-loaded PLGA implants for the treatment of ocular toxoplasmosis: Development, characterization, biocompatibility, and anti-toxoplasma activity","volume":"76","author":"Tavares","year":"2021","journal-title":"Pharmazie"},{"key":"R3-20260530","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fcimb.2020.00033","article-title":"In vitro evaluation of mannosylated paromomycin-loaded solid lipid nanoparticles on acute toxoplasmosis","volume":"10","author":"Khosravi","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R4-20260530","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s12639-021-01396-9","article-title":"Effect of spiramycin versus aminoguanidine and their combined use in experimental toxoplasmosis","volume":"45","author":"Omar","year":"2021","journal-title":"J Parasit Dis"},{"key":"R5-20260530","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jog.14184","article-title":"Seroprevalence of Toxoplasma gondii and Toxocara spp. infections among pregnant women with and without previous abortions in the west of Iran","volume":"46","author":"Raissi","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"R6-20260530","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cegh.2019.12.009","article-title":"Seroepidemiology and risk factors of toxoplasmosis among children age ranged from 1 to 14 years referred to medical diagnostic laboratories in Southeast Iran","volume":"8","author":"Raissi","year":"2020","journal-title":"Clin Epidemiol Glob Health"},{"key":"R7-20260530","first-page":"271","article-title":"Toxoplasmosis among patients with cancers and blood disorders in Iran: Serological evaluation, risk factors and comparison with healthy individuals","volume":"11","author":"Getso","year":"2021","journal-title":"J Chem Health Risks"},{"key":"R8-20260530","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.actatropica.2019.04.013","article-title":"Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis","volume":"195","author":"El-Kowrany","year":"2019","journal-title":"Acta Trop"},{"key":"R9-20260530","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12639-019-01101-x","article-title":"The relation between toxocariasis and toxoplasmosis co-infection and the presence of Rheumatoid Factor (RF) in people with hydatidosis in Southwestern Iran, from 2013 to 2018","volume":"43","author":"Fasihi Karami","year":"2019","journal-title":"J Parasit Dis"},{"key":"R10-20260530","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.2147\/IJN.S181896","article-title":"Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice","volume":"13","author":"Azami","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"R11-20260530","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejps.2018.02.018","article-title":"Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis","volume":"117","author":"Azami","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"R12-20260530","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00436-015-4759-6","article-title":"Effect of Nigella sativa oil on experimental toxoplasmosis","volume":"115","author":"Mady","year":"2016","journal-title":"Parasitol Res"},{"key":"R13-20260530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1687-7942.192997","article-title":"Applications of nanomedicine in parasitic diseases","volume":"9","author":"Abaza","year":"2016","journal-title":"Parasitol United J"},{"key":"R14-20260530","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00436-017-5458-2","article-title":"Nanomedicine advances in toxoplasmosis: Diagnostic, treatment, and vaccine applications","volume":"116","author":"Assolini","year":"2017","journal-title":"Parasitol Res"},{"key":"R15-20260530","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1007\/s11686-021-00421-4","article-title":"The high potency of green synthesized copper nanoparticles to prevent the toxoplasma gondii infection in mice","volume":"66","author":"Albalawi","year":"2021","journal-title":"Acta Parasitol"},{"key":"R16-20260530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-9053.1000140","article-title":"Copper nanoparticles as antibacterial agents","volume":"6","author":"Mahmoodi","year":"2018","journal-title":"J Mol Pharm Org Process Res"},{"key":"R17-20260530","first-page":"302","article-title":"Biochemical synthesis of copper nanoparticles using Zingiber officinalis and Curcuma longa: Characterization and antibacterial activity study","volume":"25","author":"Varghese","year":"2020","journal-title":"Materials Today: Proceedings"},{"key":"R18-20260530","doi-asserted-by":"crossref","first-page":"112245","DOI":"10.1016\/j.jinorgbio.2023.112245","article-title":"Antileishmanial effects and drugability characteristics of a heterocyclic copper complex: An in silico, in vitro and molecular study","volume":"245","author":"Mirzaei","year":"2023","journal-title":"J Inorg Biochem"},{"key":"R19-20260530","doi-asserted-by":"crossref","first-page":"012045","DOI":"10.1088\/1757-899X\/571\/1\/012045","article-title":"Determination of hemolytic cytotoxicity and antibacterial activity of Conocarpus lancifolius aqueous leaves extract","volume":"571","author":"Mohammed","year":"2019","journal-title":"InIOP Conference Series: Materials Science and Engineering"},{"key":"R20-20260530","first-page":"95","article-title":"Synthesis of copper nanoparticles biologically by conocarpus erectus L. Aqueous Leaves Extract","volume":"26","author":"Kadhim","year":"2018","journal-title":"J Univ Babylon Eng Sci"},{"key":"R21-20260530","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exppara.2017.07.009","article-title":"Activity of rosuvastatin in tachyzoites of Toxoplasma gondii (RH strain) in HeLa cells","volume":"181","author":"Sanfelice","year":"2017","journal-title":"Exp Parasitol"},{"key":"R22-20260530","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/IJN.S158736","article-title":"Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain","volume":"13","author":"Teimouri","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"R23-20260530","first-page":"224","article-title":"Cytotoxic and Immunomodulatory activity of curcumin and chitosan on experimental toxoplasmosis","volume":"19","author":"Rezgi","year":"2024","journal-title":"Iran J Parasitol"},{"key":"R24-20260530","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5812\/jamm.115282","article-title":"Anti-Toxoplasma Activity of Tellurium Oxide (TeO2) Nanoparticle on Toxoplasma gondii In vitro","volume":"9","author":"KarimiPourSaryazdi","year":"2022","journal-title":"J Arch Mil Med"},{"key":"R25-20260530","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/13543776.2012.668886","article-title":"New antibacterials for the treatment of toxoplasmosis;a patent review","volume":"22","author":"Rodriguez","year":"2012","journal-title":"Expert Opin Ther Pat"},{"key":"R26-20260530","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.matchemphys.2018.04.007","article-title":"Green synthesis and characterization of copper nanoparticles using Azadirachta indica leaves","volume":"213","author":"Nagar","year":"2018","journal-title":"Mater. Chem. Phys"},{"key":"R27-20260530","doi-asserted-by":"crossref","first-page":"101569","DOI":"10.1016\/j.bcab.2020.101569","article-title":"Green synthesis of Ag nanoparticles from pomegranate seeds extract and synthesis of Ag-Starch nanocomposite and characterization of mechanical properties of the films","volume":"25","author":"Mohseni","year":"2020","journal-title":"Biocatal Agric Biotechnol"},{"key":"R28-20260530","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4172\/pharmaceutical-sciences.1000281","article-title":"Green synthesis of stable copper nanoparticles and synergistic activity with antibiotics","volume":"79","author":"Mandava","year":"2017","journal-title":"Indian J Pharm Sci"},{"key":"R29-20260530","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"R30-20260530","doi-asserted-by":"crossref","first-page":"18835","DOI":"10.1039\/C9RA03110C","article-title":"Green-synthesized copper nanoparticles as a potential antifungal against plant pathogens","volume":"9","author":"Pariona","year":"2019","journal-title":"RSC Adv"},{"key":"R31-20260530","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.matlet.2013.10.011","article-title":"In vitro antifungal efficacy of copper nanoparticles against selected crop pathogenic fungi","volume":"115","author":"Kanhed","year":"2014","journal-title":"Materials Letters"},{"key":"R32-20260530","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s42452-020-2279-1","article-title":"Biogenic copper nanoparticles and their applications: A review","volume":"2","author":"Al-Hakkani","year":"2020","journal-title":"SN Appl Sci"},{"key":"R33-20260530","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11274-021-03000-x","article-title":"Unravelling Toxoplasma treatment: Conventional drugs toward nanomedicine","volume":"37","author":"Jafarpour Azami","year":"2021","journal-title":"World J Microbiol Biotechnol"},{"key":"R34-20260530","first-page":"593","article-title":"Antiparasitic activity of silver and copper oxide nanoparticles against entamoeba histolytica and cryptosporidium parvum cysts","volume":"45","author":"Saad","year":"2015","journal-title":"J Egypt Soc Parasitol"},{"key":"R35-20260530","first-page":"411","article-title":"In vitro assessment antiparasitic effect of selenium and copper nanoparticles on giardia deodenalis cyst","volume":"15","author":"Malekifard","year":"2020","journal-title":"Iran J Parasitol"},{"key":"R36-20260530","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/nano11040891","article-title":"Therapeutic potential of green synthesized copper nanoparticles alone or combined with meglumine antimoniate (Glucantime\u00ae) in cutaneous leishmaniasis","volume":"11","author":"Albalawi","year":"2021","journal-title":"Nanomaterials (Basel)"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_401_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:18:19Z","timestamp":1787843899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_401_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_401_23","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2023-10-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}